Brief: Exelixis Says U.S. Court Of Appeals For Federal Circuit Affirms Key Portion Of 2024 Judgment In Co's Favor
31/08/2026 19:33
BRIEF-Exelixis Says U.S. Court Of Appeals For Federal Circuit Affirms Key Portion Of 2024 Judgment In Co's Favor Aug 31 (Reuters) - Exelixis Inc EXEL.O:
EXELIXIS ANNOUNCES UPDATE ON PATENT LITIGATION TRIAL APPEAL WITH MSN LABORATORIES
EXELIXIS - U.S. COURT OF APPEALS FOR THE FEDERAL CIRCUIT AFFIRMS KEY PORTION OF 2024 JUDGMENT IN EXELIXIS' FAVOR
EXELIXIS - MSN MAY LAUNCH GENERIC CABOZANTINIB IN U.S. NO EARLIER THAN JANUARY 15, 2030
EXELIXIS - MSN LAUNCH DEPENDS ON LITIGATION OVER PATENT 12,128,039; TRIAL BEGINS NOVEMBER 2026
Source text: ID:nBw5Fkcga
Further company coverage: EXEL.O
((((Reuters.Briefs@thomsonreuters.com));))